Marie Obien

MaxWell Biosystems Completes CHF 4 million Series A Financing Round

Zurich, Switzerland, 16 December 2020 – MaxWell Biosystems AG, a spin-off from ETH Zürich founded in 2016 announced today the closing of a CHF 4 million Series A financing round to further industrialize and scale-up the production of their consumables, so called multiwell high-density microelectrode array (HD-MEA) plates. Such scale-up will enable the customers of MaxWell Biosystems in the pharmaceutical industry to run functional drug screenings at a higher throughput and ultimately contribute to accelerate the development of drugs targeting…

Read More

MaxWell Biosystems introduces its new headquarters in Zurich

Since 2016, MaxWell Biosystems was located in the same premises as the Department of Biosystems Science and Engineering at ETH Zurich in Basel. With the growing team and the need for our own headquarters, we searched and found our new home in Zurich. With the dynamic startup ecosystem, world-class universities, and of course the beautiful lake and mountains, Zurich is a great place for MxW. It is here where we will continue to grow the team, develop new products, and connect to…

Read More

Neuroservice and MaxWell Biosystems announce strategic partnership

Neuroservice and MaxWell Biosystems announce strategic partnership to develop HD-MEA assays for human iPSC-derived neurons and other cell cultures Aix-en-Provence, FRANCE and Zurich, SWITZERLAND – October 28, 2020. Today, Neuroservice and MaxWell Biosystems are thrilled to announce a strategic partnership aiming to provide the pharmaceutical industry with a new state-of-the-art CNS in vitro cell electrophysiological solution based on high-density microelectrode array recording of human iPSC-derived neurons and other neuron cultures. The partnership will combine the MaxTwo high-density microelectrode array (HD-MEA)…

Read More

MaxWell Biosystems appoints Dr. Marcel Suter as new VP Operations

Zurich, Switzerland – September 30, 2020 MaxWell Biosystems AG is pleased to announce the appointment of Dr. Marcel Suter as the new Vice President of Operations, effective September 1, 2020. In this new position, Dr. Suter will oversee the company’s operational units, including, supply chain, production, logistics, procurement, and quality control. He will report directly to Dr. Urs Frey, CEO. With more than eight years of experience as project manager and as VP Operations at Optotune, an optics company, Dr.…

Read More

Capture the activity of thousands of communicating neurons all at once

Latest Neurochip published in Nature Communications Today, a new generation of high-density microelectrode array (HD-MEA) technology has been published in Nature Communications (link). This publication not only demonstrates the excellent performance of the chip, but also describes the large-scale extraction of neuronal metrics, such as axonal conduction velocity, and includes impressive showcases of applications with various neuronal preparations. The developed versatile platform for label-free, live-cell electrical imaging will further accelerate drug discovery and basic research in the field of neuroscience.…

Read More
Contacts










Albisriederstrasse 253
8047 Zurich, Switzerland

+41 44 244 24 24

Schedule a call

info@mxwbio.com

Subscribe to our Newsletter